NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: heart failure

9/25/2018

NY Times hails MitraClip a ‘huge advance’ for heart failure, but independent sources might have said otherwise

4/10/2017

Stem cell ‘patch’ for heart failure: HealthDay cautions readers about small study size, lack of control group

12/28/2016

Experimental heart failure drug: By how much did it help? HealthDay story doesn’t say

4/6/2016

Stem cell therapy for heart failure: Reuters story covers most of the bases

1 7/10/2015

Business story on Entresto, newly approved heart failure drug, capably covers most of the health implications

8/30/2011

Electronic Nose Sniffs Out Heart Failure

11/23/2010

Implanted Heart Devices Have ‘Real-World’ Benefits: Study

11/16/2010

Gene Therapy Shows Potential Against Heart Failure